Treatment failure due to emergence of resistance to carbapenem during therapy for Shewanella algae bacteremia

Journal of Clinical Microbiology

Volumn 44, Issue 3, 2006, Pages 1172-1174

  Kim, Dong Min ^a,c   Kang, Cheol In ^a   Lee, Chang Seop ^a   Kim, Hong Bin ^a   Kim, Eui Chong ^a,b   Kim, Nam Joong ^a,b   Oh, Myoung Don ^a,b   Choe, Kang Won ^a,b  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c Chosun University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AZTREONAM; CARBAPENEM; CEFEPIME; CEFTAZIDIME; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN;

AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CASE REPORT; CEREBROSPINAL FLUID CULTURE; EPIDURAL ABSCESS; HUMAN; MALE; MINIMUM INHIBITORY CONCENTRATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; PRIORITY JOURNAL; SHEWANELLA; SHEWANELLA ALGAE; TREATMENT FAILURE; TREATMENT OUTCOME;

AGED; BACTEREMIA; BASE SEQUENCE; DNA PRIMERS; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; IMIPENEM; MALE; POLYMERASE CHAIN REACTION; SHEWANELLA; TREATMENT FAILURE;

BACTERIA (MICROORGANISMS); SHEWANELLA; SHEWANELLA ALGAE;

EID: 33644890506     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.44.3.1172-1174.2006     Document Type: Article

References (19)

1. Brink, A. J., A. van Straten, and A. J. van Rensburg. 1995. Shewanella (Pseudomonas) putrefaciens bacteremia. Clin. Infect. Dis. 20:1327-1332.
2. Buscher, K. H., and W. Cullmann. 1987. Imipenem resistance in Pseudomonas aeruginosa resulting from diminished expression of an outer membrane protein. Antimicrob. Agents Chemother. 31:703-708.
3. Butt, A. A., J. Figueroa, and D. H. Martin. 1997. Ocular infection caused by three unusual marine organisms. Clin. Infect. Dis. 24:740.
4. Dominguez, H., B. Fonnesbech Vogel, L. Gram, S. Hoffmann, and S. Schaebel. 1996. Shewanella algae bacteremia in two patients with lower leg ulcers. Clin. Infect. Dis. 22:1036-1039.
5. Drancourt, M., C. Bollet, A. Carlioz, R. Martelin, J. P. Gayral, and D. Raoult. 2000. 16S ribosomal DNA sequence analysis of a large collection of environmental and clinical unidentifiable bacterial isolates. J. Clin. Microbiol. 38:3623-3630.
6. Fass, R. J., and J. Barnishan. 1980. In vitro susceptibility of nonfermentative gram-negative bacilli other than Pseudomonas aeruginosa to 32 antimicrobial agents. Rev. Infect. Dis. 2:841-853.
7. Heritier, C., L. Poirel, and P. Nordmann. 2004. Genetic and biochemical characterization of a chromosome-encoded carbapenem-hydrolyzing ambler class D β-lactamase from Shewanella alga. Antimicrob. Agents Chemother. 48:1670-1675.
8. Iwata, M., K. Tateda, T. Matsumoto, N. Furuya, S. Mizuiri, and K. Yamaguchi. 1999. Primary Shewanella alga septicemia in a patient on hemodialysis. J. Clin. Microbiol. 37:2104-2105.
9. Khashe, S., and J. M. Janda. 1998. Biochemical and pathogenic properties of Shewanella alga and Shewanella putrefaciens. J. Clin. Microbiol. 36:783-787.
10. MacDonell, M. T., and R. R. Colwell. 1985. Phylogeny of the Vibrionaceae, and recommendation for two new genera, Listonella and Shewanella. Syst. Appl. Microbiol. 6:171-182.
11. Murchan, S., M. E. Kaufmann, A. Deplano, R. de Ryck, M. Struelens, C. E. Zinn, V. Fussing, S. Salmenlinna, J. Vuopio-Varkila, N. El Solh, C. Cuny, W. Witte, P. T. Tassios, N. Legakis, W. van Leeuwen, A. van Belkum, A. Vindel, I. Laconcha, J. Garaizar, S. Haeggman, B. Olsson-Liljequist, U. Ransjo, G. Coombes, and B. Cookson. 2003. Harmonization of pulsed-field gel electrophoresis protocols for epidemiological typing of strains of methicillin-resistant Staphylococcus aureus: a single approach developed by consensus in 10 European laboratories and its application for tracing the spread of related strains. J. Clin. Microbiol. 41:1574-1585.
12. National Committee for Clinical Laboratory Standards. 2003. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 6th ed. Approved standard M7-A6. National Committee for Clinical Laboratory Standards, Wayne, Pa.
13. National Committee for Clinical Laboratory Standards. 2003. Performance standards for antimicrobial disk susceptibility tests, 8th ed. M2-A8. National Committee for Clinical Laboratory Standards, Wayne, Pa.
14. Pagani, L., A. Lang, C. Vedovelli, O. Moling, G. Rimenti, R. Pristera, and P. Mian. 2004. Soft tissue infection and bacteremia caused by Shewanella putrefaciens. J. Clin. Microbiol. 41:2240-2241.
15. Pickett, M. J., D. G. Hollis, and E. J. Bottone. 1991. Miscellaneous gram-negative bacteria, p. 410-428. In A. Balows, W. J. Hausler, K. L. Herrmann, H. D. Isenberg, and H. J. Shadomy (ed.), Manual of clinical microbiology, 5th ed. American Society for Microbiology, Washington, D.C.
16. Quinn, J. P., and A. E. Studemeister. 1988. Resistance to imipenem in Pseudomonas aeruginosa: clinical experience and biochemical mechanisms. Rev. Infect. Dis. 10:892-898.
17. Quinn, J. P., E. J. Dudek, C. A. Divincenzo, D. A. Lucks, and S. A. Lerner. 1986. Emergence of resistance of imipenem during therapy for Pseudomonas aeruginosa infections. J. Infect. Dis. 154:289-294.
18. Tenney, J. H., R. W. Maack, and G. R. Chippenedale. 1983. Rapid selection of organisms with increasing resistance on subinhibitory concentrations of norfloxacin in agar. Antimicrob. Agents Chemother. 23:188-189.
19. Weisburg, W. G., S. M. Barns, D.A. Pelletier, and D. J. Lane. 1991. 16S ribosomal DNA amplification for phylogenetic study. J. Bacteriol. 173:697-703.